Cardiac Implications of an Exercise Prescription
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
How close are we to tailoring exercise programs to patients based on their level of cardiac health? One study, conducted by Dr. Aaron Baggish, a cardiology fellow at Massachusetts General Hospital and the lead author of research published in the Journal of Applied Physiology, reveals the specific cardiac structure and function changes in a group of university aged athletes when comparing the effects of strength vs. endurance exercise. Your host, Dr. Lee Freedman, discusses with Dr. Baggish the variance observed in ventricular dilation, wall thickness, diastolic function, and other areas between the two groups, and the potential this study could have in the exam room.
Overview
How close are we to tailoring exercise programs to patients based on their level of cardiac health? One study, conducted by Dr. Aaron Baggish, a cardiology fellow at Massachusetts General Hospital and the lead author of research published in the Journal of Applied Physiology, reveals the specific cardiac structure and function changes in a group of university aged athletes when comparing the effects of strength vs. endurance exercise. Your host, Dr. Lee Freedman, discusses with Dr. Baggish the variance observed in ventricular dilation, wall thickness, diastolic function, and other areas between the two groups, and the potential this study could have in the exam room.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway
Evolving Our View of the Coagulation Cascade and Stroke Management
M3: Managing the Cardiometabolic Risk in MASH
Maximizing Adherence and Persistence via Patient Engagement
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Impact of Barostim on Heart Failure Hospitalization
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?